Alemtuzumab Combined With Etoposide, Vincristine, Doxorubicin, Cyclophosphamide, and Prednisone in Treating Patients Who Have Not Received Chemotherapy For T-Cell or NK-Cell Lymphoma
This study is ongoing, but not recruiting participants.
Study NCT00072254
Information provided by National Cancer Institute (NCI)
First Received: November 4, 2003
Last Updated: March 31, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
